Back to news
finance

Major Stock Market Movers on Wednesday: Nike, Bloom Energy See Notable Shifts

Several prominent companies experienced significant stock price movements on Wednesday, drawing attention from investors. These shifts affected various sectors, including athletic apparel and energy solutions.

7/23/2026, 7:17:00 AM

Wednesday trading saw considerable activity among several corporations, with their share prices experiencing notable changes. Among these, Nike (NYSE:NKE) and Bloom Energy (NYSE:BE) were particularly prominent, as highlighted by Seeking Alpha. Nike’s stock observed a downward trend during the day’s trading. This decline followed the company's investor day event, where new financial projections were shared with the market. Despite these updated forecasts, the immediate reaction from investors appeared to be cautious, leading to the shares moving lower. Conversely, Bloom Energy (NYSE:BE) experienced a substantial increase in its stock value. The positive momentum for the energy company stemmed from an announcement regarding a new strategic alliance. This partnership is with an arm of Shell, specifically Shell New Energies, and centers on the development of large-scale renewable energy projects. Collaboration with a major energy player like Shell was met with enthusiasm by the market, driving Bloom Energy's stock upwards. In other market news, several pharmaceutical companies also saw significant fluctuations. Acorda Therapeutics (NASDAQ:ACOR) demonstrated considerable gains. This surge in value came after the company released an update concerning its legal proceedings. A favorable ruling in a patent infringement case provided a clear boost to investor confidence. Additionally, shares of Agenus (NASDAQ:AGEN) also climbed. This upturn was connected to new developments in their clinical trials, specifically regarding their oncology treatments. Positive readouts from these studies generated optimism about the future prospects of their drug candidates. On the downside, Mirati Therapeutics (NASDAQ:MRTX) experienced a decline. The decrease followed the presentation of data from their clinical pipeline. While specific details were not immediately available, the market reaction suggested that the presented information did not meet investor expectations, leading to a sell-off. Overall, Wednesday's trading session presented a mixed picture across different industries, with company-specific news playing a crucial role in the individual performances of these major movers.

Share